Egr2 and GRAIL are linked with the development of an anergic-like T cell phenotype in Type 2 (Fasciola hepatica) and Type 1 (Trypanosoma cruzi and Mycobacterium tuberculosis) infection settings [17,46,47]. Here, EGR2 is linked to infection.